HDAC11-AS1: A Potential Drug Target and Biomarker (G100874101)

Target Name: HDAC11-AS1

NCBI ID: G100874101

HDAC11-AS1

Other Name(s): HDAC11 antisense RNA 1 | HDAC11 antisense RNA 1 (non-protein coding)

HDAC11-AS1: A Potential Drug Target and Biomarker

Hairless-associated gene (HAG) is a tumor suppressor gene that is often mutated in various diseases, including cancer. The HDAC11 gene, which encodes a histone deacetylase (HDAC) enzyme, has been identified as a potential drug target and biomarker for various diseases, including cancer.

The HDAC11 gene has been shown to play a crucial role in the regulation of cell growth, apoptosis, and autophagy. It is a key enzyme in the histone deacetylase (HDAC) family, which is involved in the removal of acetyl groups from histones, which are the proteins that make up the nucleosome. The removal of these acetyl groups is important for the regulation of chromatin structure and the maintenance of genomic stability.

Mutations in the HDAC11 gene have been implicated in the development of various diseases, including cancer. For example, mutations in the HDAC11 gene have been shown to be associated with the development of breast cancer. Researchers have also found that HDAC11 mutations are frequently observed in various types of cancer, including colon cancer and lung cancer.

In addition to its role in cancer development, the HDAC11 gene has also been shown to play a potential drug target. The HDAC11 enzyme has been shown to have a role in the regulation of cellular processes that are important for cancer growth and progression. For example, HDAC11 has been shown to play a role in the regulation of cell adhesion, a process that is important for the development of cancer stem cells.

The HDAC11 gene has also been shown to be involved in the regulation of cellular processes that are important for aging and age-related diseases. For example, HDAC11 has been shown to play a role in the regulation of telomere length, a process that is important for the length of telomeres, which are the protective caps at the ends of chromosomes. The shortening of telomeres has been associated with aging and age-related diseases, including cancer and cardiovascular disease.

In addition to its potential drug target and biomarker properties, the HDAC11 gene has also been shown to have a role in the regulation of cellular processes that are important for normal development and maintenance. For example, HDAC11 has been shown to play a role in the regulation of cell proliferation, a process that is important for the development and maintenance of tissues and organs.

Overall, the HDAC11 gene has been identified as a potential drug target and biomarker for various diseases, including cancer. Further research is needed to fully understand the role of HDAC11 in these diseases and to develop effective treatments.

Protein Name: HDAC11 Antisense RNA 1

The "HDAC11-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HDAC11-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets